These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 8222045
1. CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Vanden Heuvel JP, Clark GC, Thompson CL, McCoy Z, Miller CR, Lucier GW, Bell DA. Carcinogenesis; 1993 Oct; 14(10):2003-6. PubMed ID: 8222045 [Abstract] [Full Text] [Related]
2. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. van Duursen MB, Sanderson JT, van den Berg M. Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568 [Abstract] [Full Text] [Related]
4. Cell-specific differences in the susceptibility of potential cellular targets of human origin derived from blood and lung following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Lang DS, Becker S, Devlin RB, Koren HS. Cell Biol Toxicol; 1998 Feb; 14(1):23-38. PubMed ID: 9538942 [Abstract] [Full Text] [Related]
11. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G, Caporaso NE. Pharmacogenetics; 1994 Oct; 4(5):242-6. PubMed ID: 7894496 [Abstract] [Full Text] [Related]
12. Expression of the CYP1A1 gene in peripheral lymphocytes as a marker of exposure to creosote in railroad workers. Cosma GN, Toniolo P, Currie D, Pasternack BS, Garte SJ. Cancer Epidemiol Biomarkers Prev; 1992 Oct; 1(2):137-42. PubMed ID: 1306096 [Abstract] [Full Text] [Related]
13. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Walker NJ, Portier CJ, Lax SF, Crofts FG, Li Y, Lucier GW, Sutter TR. Toxicol Appl Pharmacol; 1999 Feb 01; 154(3):279-86. PubMed ID: 9931287 [Abstract] [Full Text] [Related]
14. Cytochrome P450 1A1 expression and activity in Caco-2 cells: modulation by apple juice extract and certain apple polyphenols. Pohl C, Will F, Dietrich H, Schrenk D. J Agric Food Chem; 2006 Dec 27; 54(26):10262-8. PubMed ID: 17177569 [Abstract] [Full Text] [Related]
15. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Larsen MC, Angus WG, Brake PB, Eltom SE, Sukow KA, Jefcoate CR. Cancer Res; 1998 Jun 01; 58(11):2366-74. PubMed ID: 9622076 [Abstract] [Full Text] [Related]
16. Inhibitory effects of vitamin A on TCDD-induced cytochrome P-450 1A1 enzyme activity and expression. Yang YM, Huang DY, Liu GF, Zhong JC, Du K, Li YF, Song XH. Toxicol Sci; 2005 May 01; 85(1):727-34. PubMed ID: 15728703 [Abstract] [Full Text] [Related]
17. Cytochrome P450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. Bapiro TE, Andersson TB, Otter C, Hasler JA, Masimirembwa CM. Eur J Clin Pharmacol; 2002 Nov 01; 58(8):537-42. PubMed ID: 12451431 [Abstract] [Full Text] [Related]
18. Detection of CYP1A1 mRNA levels and CYP1A1 Msp polymorphisms as possible biomarkers of exposure and susceptibility in smokers and non-smokers. Rumsby PC, Yardley-Jones A, Anderson D, Phillimore HE, Davies MJ. Teratog Carcinog Mutagen; 1996 Nov 01; 16(1):65-74. PubMed ID: 8792534 [Abstract] [Full Text] [Related]
19. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene. Harrigan JA, McGarrigle BP, Sutter TR, Olson JR. Toxicol In Vitro; 2006 Jun 01; 20(4):426-38. PubMed ID: 16198082 [Abstract] [Full Text] [Related]